On November 10, Mosaic saw an Intraday Rise of 5.17% in Regular Trading, with shares trading at $23.455 and turnover of $86.855 million.
The move coincided with a fresh analyst note indicating that while a recovery in the phosphate market is likely to take time, cost-cutting measures and lower capital spending should support moderate cash generation.
Recent context has been mixed. Mosaic reported a third-quarter adjusted loss of $0.19 per share on net sales of $3.10 billion, versus expectations for a $0.01 loss and about $3.05 billion in revenue. Separately, an analyst lowered its price target to $23 from $25 while maintaining a neutral-equivalent rating, underscoring near-term uncertainty even as spending restraint may help cash flow.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments